{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:27:01Z","timestamp":1794508021509,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4165-4","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T08:32:05Z","timestamp":1520584325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-6694","authenticated-orcid":false,"given":"Mette","family":"Tranberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Blaak\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Svanholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"issue":"15","key":"4165_CR1","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","volume":"45","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45(15):2640\u20138.","journal-title":"Eur J Cancer"},{"key":"4165_CR2","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1136\/bmj.e900","volume":"344","author":"B Andrae","year":"2012","unstructured":"Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S, Sparen P. Screening and cervical cancer cure: population based cohort study. BMJ. 2012;344:e900.","journal-title":"BMJ"},{"issue":"5","key":"4165_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/bjc.2014.362","volume":"111","author":"S Vaccarella","year":"2014","unstructured":"Vaccarella S, Franceschi S, Engholm G, L\u00f6nnberg S, Khan S, Bray F. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer. 2014;111(5):965\u20139.","journal-title":"Br J Cancer"},{"issue":"12","key":"4165_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0959-8049(00)00122-2","volume":"36","author":"Advisory Committee","year":"2000","unstructured":"Advisory Committee. Recommendations on cancer screening in the European union. Advisory committee on cancer prevention. Eur J Cancer. 2000;36(12):1473\u20138.","journal-title":"Eur J Cancer"},{"issue":"1","key":"4165_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/14737140.2014.856273","volume":"14","author":"RP Bosgraaf","year":"2014","unstructured":"Bosgraaf RP, Siebers AG, De Hullu JA, Massuger LF, Bulten J, Bekkers RL, Melchers WJ. The current position and the future perspectives of cervical cancer screening. Expert Rev Anticancer Ther. 2014;14(1):75\u201392.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"4165_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jnci\/djn099","volume":"100","author":"B Andrae","year":"2008","unstructured":"Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100(9):622\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4165_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/sj.bjc.6604293","volume":"98","author":"O Ingemann-Hansen","year":"2008","unstructured":"Ingemann-Hansen O, Lidang M, Niemann I, Dinesen J, Baandrup U, Svanholm H, Petersen L. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br J Cancer. 2008;98(7):1292\u20134.","journal-title":"Br J Cancer"},{"issue":"2","key":"4165_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","volume":"45","author":"AR Spence","year":"2007","unstructured":"Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007;45(2):93\u2013106.","journal-title":"Prev Med"},{"issue":"4","key":"4165_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1258\/jms.2009.009073","volume":"16","author":"J Waller","year":"2009","unstructured":"Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009;16(4):199\u2013204.","journal-title":"J Med Screen"},{"issue":"46","key":"4165_CR10","first-page":"4371","volume":"167","author":"M Espersen","year":"2005","unstructured":"Espersen M, Holten I. Barrierer for screening for livmoderhalskr\u00e6ft. Ugeskr Laeger. 2005;167(46):4371\u20135.","journal-title":"Ugeskr Laeger"},{"issue":"9916","key":"4165_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"5","key":"4165_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry K, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P. Overview of the European and north American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095\u2013101.","journal-title":"Int J Cancer"},{"issue":"2","key":"4165_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P, Anttila A. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172\u201383.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4165_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/1055-9965.EPI-14-1417","volume":"24","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomark Prev. 2015;24(5):769\u201372.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"4165_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","volume":"93","author":"EJ Nelson","year":"2017","unstructured":"Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017;93(1):56\u201361.","journal-title":"Sex Transm Infect"},{"issue":"16","key":"4165_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey C, Snijders P, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375\u201385.","journal-title":"Eur J Cancer"},{"issue":"6","key":"4165_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","volume":"104","author":"A Szarewski","year":"2011","unstructured":"Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A. HPV self-sampling as an alternative strategy in non-attenders for cervical screening\u2013a randomised controlled trial. Br J Cancer. 2011;104(6):915\u201320.","journal-title":"Br J Cancer"},{"issue":"3","key":"4165_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bjc.2011.236","volume":"105","author":"I Wikstrom","year":"2011","unstructured":"Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337\u20139.","journal-title":"Br J Cancer"},{"issue":"9","key":"4165_CR19","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.28545","volume":"134","author":"G Broberg","year":"2014","unstructured":"Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd ML, Holtenman M, Milsom I, Strander B. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer. 2014;134(9):2223\u201330.","journal-title":"Int J Cancer"},{"issue":"2","key":"4165_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","volume":"104","author":"PG Rossi","year":"2011","unstructured":"Rossi PG, Marsili L, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104(2):248\u201354.","journal-title":"Br J Cancer"},{"issue":"4","key":"4165_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/bjc.2015.11","volume":"112","author":"PG Rossi","year":"2015","unstructured":"Rossi PG, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, Ferro A, Giammaria C, Manfredi M, Moretto T. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer. 2015;112(4):667\u201375.","journal-title":"Br J Cancer"},{"key":"4165_CR22","unstructured":"Kitchener H, Gittins M, Cruickshank M, Moseley C, Fletcher S, Albrow R, Gray A, Brabin L, Torgerson D, Crosbie EJ, Sargent A, Roberts C. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: the STRATEGIC trial. J Med Screen. 2017;0(0):1-11."},{"issue":"11","key":"4165_CR23","first-page":"2681","volume":"133","author":"H Sancho-Garnier","year":"2013","unstructured":"Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, Heid P, Davies P, Piana L. HPV self-sampling or the pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer. 2013;133(11):2681\u20137.","journal-title":"Int J Cancer"},{"issue":"1","key":"4165_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-016-2859-z","volume":"16","author":"M Tranberg","year":"2016","unstructured":"Tranberg M, Bech BH, Blaak\u00e6r J, Jensen JS, Svanholm H, Andersen B. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program. BMC Cancer. 2016;16(1):835\u201341.","journal-title":"BMC Cancer"},{"key":"4165_CR25","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1136\/bmj.a2390","volume":"337","author":"M Zwarenstein","year":"2008","unstructured":"Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. CONSORT group, pragmatic trials in healthcare (Practihc) group: improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:2390.","journal-title":"BMJ"},{"key":"4165_CR26","unstructured":"Danmarks Statistik [in English Statistic Denmark]. Available at \n                    \n                      www.statistikbanken.dk\n                    \n                    \n                  . Accessed June 2017."},{"issue":"7 Suppl","key":"4165_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1403494810393563","volume":"39","author":"B Bjerregaard","year":"2011","unstructured":"Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72\u20134.","journal-title":"Scand J Public Health"},{"issue":"8","key":"4165_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"4165_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and data Bank. Clin Epidemiol. 2010;2:51\u20136.","journal-title":"Clin Epidemiol"},{"key":"4165_CR30","unstructured":"The Danish Health and Medicines Authority (2012): Screening for livmoderhalskr\u00e6ft-anbefalinger 2012 [In English: Cervical cancer screening-recommendations]. Copenhagen [in Danish with English summary]."},{"issue":"1","key":"4165_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12889-015-2039-0","volume":"15","author":"M Tranberg","year":"2015","unstructured":"Tranberg M, Larsen MB, Mikkelsen EM, Svanholm H, Andersen B. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. BMC Public Health. 2015;15(1):681\u201393.","journal-title":"BMC Public Health"},{"issue":"2","key":"4165_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"12","key":"4165_CR33","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1128\/JCM.01506-12","volume":"50","author":"R van Baars","year":"2012","unstructured":"van Baars R, Bosgraaf RP, ter Harmsel BW, Melchers WJ, Quint WG, Bekkers RL. Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol. 2012;50(12):3937\u201343.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"4165_CR34","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/JCM.03386-12","volume":"51","author":"A Rao","year":"2013","unstructured":"Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, Apple R, Behrens C. Development and characterization of the cobas human papillomavirus test. J Clin Microbiol. 2013;51(5):1478\u201384.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"4165_CR35","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ijc.25581","volume":"128","author":"A Virtanen","year":"2011","unstructured":"Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer. 2011;128(11):2681\u20137.","journal-title":"Int J Cancer"},{"key":"4165_CR36","unstructured":"Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening, \u00e5rsrapport 2013. [in English: The Danish Quality Database for Cervical Cancer Screening, report 2013]. 2014."},{"key":"4165_CR37","unstructured":"Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening, \u00e5rsrapport 2015. [in English: The Danish Quality Database for Cervical Cancer Screening, report 2015]. 2016."},{"key":"4165_CR38","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/bmj.c1040","volume":"340","author":"M Gok","year":"2010","unstructured":"Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Belien JA, Babovic M, Snijders PJ, Meijer CJ. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:1040.","journal-title":"BMJ"},{"issue":"5","key":"4165_CR39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ijc.26128","volume":"130","author":"M Gok","year":"2012","unstructured":"Gok M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Belien JA, Babovic M, Snijders PJ, Meijer CJ. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer. 2012;130(5):1128\u201335.","journal-title":"Int J Cancer"},{"issue":"10","key":"4165_CR40","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/ijc.30647","volume":"140","author":"JUH Lam","year":"2017","unstructured":"Lam JUH, Rebolj M, M\u00f8ller Ejegod D, Pedersen H, Rygaard C, Lynge E, Thirstrup Thomsen L, Kr\u00fcger Kjaer S, Bonde J. Human papillomavirus self-sampling for screening nonattenders: opt-in pilot implementation with electronic communication platforms. Int J Cancer. 2017;140(10):2212\u20139.","journal-title":"Int J Cancer"},{"key":"4165_CR41","doi-asserted-by":"crossref","unstructured":"Kristensson JH, Sander BB, Lynge E. Predictors of non-participation in cervical screening in Denmark. Cancer Epidemiol. 2014:38(2):174-90.","DOI":"10.1016\/j.canep.2013.12.007"},{"issue":"2","key":"4165_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.30031","volume":"139","author":"F Sultana","year":"2016","unstructured":"Sultana F, English DR, Simpson JA, Drennan KT, Mullins R, Brotherton JM, Wrede CD, Heley S, Saville M, Gertig DM, Home-based HPV. Self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia. Int J Cancer. 2016;139(2):281\u201390.","journal-title":"Int J Cancer"},{"issue":"1","key":"4165_CR43","doi-asserted-by":"publisher","first-page":"e0147326","DOI":"10.1371\/journal.pone.0147326","volume":"11","author":"M Rebolj","year":"2016","unstructured":"Rebolj M, Bonde J, Preisler S, Ejegod D, Rygaard C, Lynge E. Human papillomavirus assays and cytology in primary cervical screening of women aged 30 years and above. PLoS One. 2016;11(1):e0147326.","journal-title":"PLoS One"},{"issue":"7","key":"4165_CR44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.22484","volume":"120","author":"AG Bais","year":"2007","unstructured":"Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120(7):1505\u201310.","journal-title":"Int J Cancer"},{"issue":"12","key":"4165_CR45","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.ejca.2011.11.022","volume":"48","author":"M Gok","year":"2012","unstructured":"Gok M, Heideman DA, van Kemenade FJ, de Vries AL, Berkhof J, Rozendaal L, Belien JA, Overbeek L, Babovic M, Snijders PJ, Meijer CJ. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer. 2012;48(12):1799\u2013808.","journal-title":"Eur J Cancer"},{"key":"4165_CR46","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30:F88\u201399.","journal-title":"Vaccine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T19:11:01Z","timestamp":1552072261000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4165-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Danish Data Protection Agency (j.no: 1\u201316\u201302-495-15) and by the Danish Health Authorities (j.no: 3\u20133013-1407\/1). Furthermore, the study achieved clearance at the Central Denmark Region Committees on Health Research Ethics (j.no: 1\u201310\u201372-259-15). The included women were informed that if they returned their self-sample they thereby expressed their consent to participate in the study\n                      .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Axlab, the Danish manufacturer of Evalyn\u00ae Brush, and Roche, the manufacturer of the Cobas\u00ae 4800 HPV DNA assay, provided self-sampling devices and test kits for the study. According to the contract between the manufacturers and the Department of Public Health Programmes, Randers Regional Hospital, Axlab and Roche had no influence on the scientific process and no editorial rights pertaining to this manuscript. The authors retained the right to submit the manuscript. None of the authors were compensated for their work on this study, have any shares in the manufacturers\u2019 companies, or received bonuses from any of the manufacturers. All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"273"}}